Abstract Motor function declines with increasing adult age. Proper regulation of the balance between dopamine (DA) and acetylcholine (ACh) in the striatum has been shown to be fundamentally important for motor control. Although other factors can also contribute to this ageassociated decline, a decrease in the concentration and binding potential of the DA D 2 receptor subtype in the striatum, especially in the cholinergic interneurons, are involved in the mechanism. Our studies have shown that gene transfer of the DA D 2 receptor subtype with adenoiviral vectors is effective in ameliorating ageassociated functional decline of the striatal cholinergic interneurons. These achievements confirm that an ageassociated decrease of D 2 R contributes functional alteration of the interaction of DA and ACh in the striatum and demonstrate that these age-associated changes indeed are modifiable.
Introduction
Motor function declines with increasing adult age (Potvin et al. 1980; Kolb et al. 1998 ). The mechanisms of this age-associated decline of motor function are complex and multifactorial. They include changes in musculoskeletal architecture (Lexell 1997; Dutta et al. 1997 ) and both peripheral and central nerve conduction (Dorfman and Bosley 1979; Delbono 2003) .
The nigrostriatal system has also been implicated in the decline of motor function in senescence. Pharmacological interference of dopamine (DA) synthesis (Rech et al. 1966) , blockade of receptor binding of DA (Carp and Anderson 1979) , or destruction of dopaminergic neurons (Kozlowski and Marshall 1981) have been demonstrated to induce motor functional impairment similar to that observed in aged animals. Age-related structural alterations in the nigrostriatum system with aging have also been established. Although the issue of an age-related decrease in the number of nigral cells remains controversial (Stark and Pakkenberg 2004) , agerelated decline in striatal DA levels (Carlsson and Winblad 1976) and DA receptors, specifically D 2 R subtype (Morgan and Finch 1988; Joseph et al. 1990 ), have been repeatedly reported. Moreover, almost 30 years ago, Marshall and Berrios demonstrated that DA injections improved swimming performance in aged rats (Marshall and Berrios 1979) , and pharmacological interventions to increase the DA receptor density have been shown to enhance motor function in senescent rats (Joseph and Roth 1988a) . Taken altogether, the alteration of dopaminergic systems may contribute the age-associated motor functional decline.
Structure of the striatum
The striatum is one of the main structures of the basal ganglia, which receives various inputs from several brain regions, including the cortex, substantia nigra, and thalamus. Principal projecting neurons in the striatum are medium-sized cells (10-20 µm diameter) with spiny dendrites [medium spiny (MS) cells]. MS cells occupy 95% of the striatal neuronal population. The other neuronal population consists of interneurons, and several types of interneurons have been identified. There are three types of GABAergic interneurons in the striatum, distinguished by neurochemical characteristics, and cholinergic interneurons also have been identified (Tepper and Bolam 2004) .
Cholinergic interneurons are the largest aspiny neurons (20-50 µm diameter, 300-2,000 µm 2 ), accounting for less than 2% of total neuronal population in the striatum (Pisani et al. , 2001 . The axons of interneurons extend well into the striatum and also possess widespread dendritic trees (Graybiel 1990) . In terms of localization, these cells form pairs with MS cells and provide modulatory interactions on output signals from the striatum (Mensah 1980; Pickel and Chan 1991) . Based on these features, these interneurons appear able to integrate synaptic inputs and project over large regions within the striatum.
Compared with other brain regions, the striatum possesses one of the highest contents of ACh despite the relatively small occupancy of the cholinergic interneurons in striatal neuronal populations. Several studies demonstrated that cholinergic interneurons receive dopaminergic inputs from the substantia nigra and glutamatergic inputs from the neocortex (Dimova et al. 1993; Chang 1988; Kubota et al. 1987; Bolam and Bennett 1995; Lapper and Bolam 1992) . However, not all the reports have confirmed dopaminergic terminals at synapses of cholinergic interneurons (Pickel and Chan 1990) . Because tyrosine hydroxylase (TH) and choline acetyl transferase (ChAT) immunoreactive terminals are closely positioned, possibly to allow simple diffusion of neurotransmitters as they are released, the possibility that DA is regulating the activity of cholinergic cells in a nonsynaptic way also exists (Stoof et al. 1992) as well as in a synaptic way. Reciprocally, ACh also transmits the inputs to DA neurons by both synaptic and nonsynaptic mechanisms (Contant et al. 1996) .
Functional interactions between dopaminergic and cholinergic neurons in the striatum
Proper regulation of the balance between DA and ACh in the striatum has been known to be fundamentally important for motor control (Di Chiara et al. 1994; . The apomorphineinduced rotational model has been well established to evaluate asymmetrical D 2 R distributions in the striata, typically following a unilateral injection of 6-hydroxydopamine (6OHDA) into the substantia nigra. (Pycock 1980) . The unilateral dopaminergic innervation to the striatum is markedly reduced by the toxic effects of 6OHDA, and upregulation of striatal D 2 R in the lesioned side is observed. With this alteration in the nigrostriatal system, following a systemic injection of the DA agonist, apomorphine, 6OHDA-lesioned rats display a stereotypic rotational behavior in the direction contralateral to the lesioned side where the D 2 R upregulation occurs. Kaneko and coworkers demonstrated that the neurochemical ablation of unilateral cholinergic neurons in the striatum could induce ipsilateral rotational behavior following systemic apomorphine (DA agonist) injection, suggesting cholinergic dysfunction could also change the dopaminergic neuronal functions (Kaneko et al. 2000) . These experiments clearly demonstrated that ACh-DA interaction was regulated to coordinate straital synaptic integration.
Regarding clinical issues, patients with Parkinson's disease, who have reduced DA binding to the striatal receptors because of dopaminergic neuronal loss in the substantia nigra, show impaired extrapyramidal motor function (Fahn 2003) . Some of the symptoms of this disease can also be alleviated by inhibiting ACh activities (Berg et al. 1987) . These findings also suggest that ACh-DA interactions in the striatum are important in regulating motor function. Yan et al. (1997) reported that all the cholinergic interneurons possess the DA D 2 subtype of receptor, and 90% of the cells coexpressed D 1 type. Dopaminergic regulation of straital ACh is reciprocal, i.e., DA D 2 receptor is inhibitory, while the D 1 receptor is stimulatory (DeBoer et al. 1996; Di Chiara et al. 1994 ). Activation of D 2 R in cholinergic interneurons reduces the N-type calcium currents through the protein kinase C pathway to modulate the excitability of the cell and reduce ACh release (Yan et al. 1997; Pisani et al. 2000; Maurice et al. 2004; Stoof et al. 1992) Age-assocaited changes of DA and ACh interactions in the striatum An age-associated decrease in the concentration or binding potential of D 2 R in the striatum has been documented in a variety of species ranging from rodents to humans. The hypothesized mechanisms of these decrements are both molecular and cellular (Roth and Joseph 1994) . At the molecular level, the biosynthesis of the D 2 R has been shown to be reduced in the aged striatum (Henry and Roth 1984; Henry et al. 1987; Norman et al. 1987) , and the concentration of mRNA for this receptor also decreases with advancing age (Della Vedova et al 1992; Weiss et al. 1992) . At the cellular level, approximately 20% of the striatal neurons are lost (Han et al. 1989 ). In effect, in the mammalian brain there appears to be about a 30-50% loss of D 2 R in the aged striata.
No direct evidence has indicated the age-associated decrease of D 2 R on the interneuron. However, Zhang and co-workers evaluated D 2 R mRNA levels in the striatum neurons according to cellular size. They concluded that the significant decrease in D 2 R mRNA appeared in positive large neurons (over 210 µm 2 ), which were probably were interneurons .
Age-associated changes in the striatal cholinergic system have also been reported. The baseline release of ACh in the striatum was decreased in aged rats compared with young rats (Wu et al. 1988; Wang et al. 2007) . A decline of cholinergic activity in the striatum was suggested by several studies (Sherman and Friedman 1990; Ogawa et al. 1994; Zambrzycka et al. 2002) . The activity of cholinesterase, which degrades ACh, was also decreased by age (Das et al. 2001) . Using a striatal slice preparation, Joseph and Roth (1988b) reported reduced inhibition of ACh release by apomorphine in aged rats compared with young and middle-aged rats.
We also investigated the age-asociated changes of DA and Ach interactions in the striatum by in-vivo microdialysis. The effects of different concentrations of a D 2 R agonist, quinpirole, on the striatal ACh release in three groups of rats at different ages (6-, 15-, 25-months old) were examined. The infusion of quinpirole into the striatum decreased ACh levels in all three age group as shown in Fig. 1 . Significant differences between the effects of the two doses of quinpirole were found in the young and old rats (P<0.05) (Fig. 1a,c) , but not in the middle-aged rats (Fig. 1b) . In the mean levels of ACh release (120-220 min) suppressed by quinpirole, there were significant differences between the middle-aged and old rats (P<0.05) at the dose of 0.1 μM quinpirole (Fig. 2a) , and between the young and old rats (P<0.05) at the dose of 1 μM quinpirole (Fig. 2b) . These data suggested that the striatal DA-ACh interaction was affected in aged animals . The reason why there were no dose-dependent effects in the middleaged rats was unclear; however, we speculate that supersensitivity of D 2 R induced by a slight decrease of D 2 R numbers in middle-aged rats may exert an almost full response by a lower dose of D 2 R agonist.
After considering the results discussed above, we can offer the following hypothesis: the age-related decrease in D 2 R concentration could lead to a "cascade" of intrastriatal effects that initially change the reciprocal inhibitory control between ACh and DA, leading to diminutions in motor performance. We could propose that one way of testing this hypothesis would be to determine if restorations of age-associated decreased D 2 R signaling in the striatal interneurons could ameliorate the functional impairments of ACh-DA interactions.
Interventions to ameloriate the decline in ageassociated DA-ACH interactions in the striatum There are several ways of supplementing dopaminergic input in aged nigrostrial systems. One of these ways is by introducing intrastriatal nigral grafts. Such grafts have been shown to improve movement coordination in aged rats (Gage et al. 1983) , which suggested that age-associated motor functional impairment was at least partly due to reduced strialtal dopminergic input, and the supplement of dopami-nergic input could ameriolate these impairments. Another important suggestion which these graft studies gave us was that intrastriatal nigral grafts restored cholinergic interneuronal function via actions at DA receptors located on interneurons (Herman et al. 1988; Jackisch et al. 1991) . The increased input of DA receptors on interneurons is possibly needed to restore the age-associated functional decline in DAACh interactions and could ameliorate motor function deficits (Puschban et al. 2000) . Another strategy to manipulate the D 2 R density in the striatum is gene transfer. This intervention would provide a more specific manipulation of DA function than offered by neural tissue grafting. To this end, we developed methods using adenoviral vectors for intracerebral D 2 R gene transfer.
Vector construction
Details of the vector construction are documented elsewhere (Ikari et al. 1995) . In brief, the vector was constructed by deletion of the majority of E1 and a portion of E3 region, and insertion of an expression cassette containing the rat D 2 R cDNA along with the cytomegalovirus immediate early promoter and enhancer (AdCMV.DopD 2 R).
In-vitro expression
By using HeLa cell lines, which normally do not express D 2 R, the viability of the viral vector, AdCMV.DopD 2 R was confirmed in vitro. In membrane preparations extracted from HeLa cells infected with AdCMV.DopD 2 R, specific binding of [ 3 H] spiperone, a D 2 R ligand, was very evident showing the protein expression of D 2 R in cellular membrane along with abundant mRNA production.
In-vivo expression and functional assessment
Autoradiographic studies demonstrated that this vector system accomplished similar D 2 R overexpression in the brains of Sprague-Dawley and Fischer-344 rats (Fig. 3 ) (Umegaki et al. 1997; Ingram et al. 1998 ). However, the overexpression of D 2 R was transient. The maximum expression was observed as early as 2 or 3 days after vector injection, and expression had declined to almost baseline levels by 3 weeks post-injection (Fig. 4) .
To determine if the expressed D 2 R by AdCMV. DopD 2 R was functional, we selected to use the apomorphine-induced rotational model described earlier (Pycock 1980) . The unilateral striatal injection of the adenoviral vectors would be designed to induce upregulation of D 2 R similar to what occurs in the injected side to 6OHDA lesioned rats. We would then expect to observe rotational behavior toward the ipsolateral side of the injection. By using this model, we demonstrated that striatal D 2 R induced by the gene transfer with the AdCMV.DopD 2 R was functional (Fig. 5) despite the non-selective character of the gene transfer; i.e., many different types of neurons and glia appeared to be expressing D 2 R following the vector treatment.
Expression in aged rats
By taking advantage of PET technology designed for small animals (Ogawa et al. 2000; Umegaki et al. 2002) , we showed that AdCMV.DopD 2 R-mediated gene transfer of D 2 R was feasible in aged rats (Figs. 6,  7) . We also found that the overexpression period of D 2 R induced by gene transfer was longer in aged rats than in young rats (Fig. 8) .
Application of gene transfer to age-associated alterations in DA-ACh interactions
To test the hypothesis that D 2 R augmentation by adenoviral vector-mediated gene transfer could ameliorate the control of the ACh release by DA, we performed microdialysis studies of vector-injected rats (Umegaki et al. 2006 ). Quinpirole, a specific D 2 R agonist (Sigma, St. Louis, Mo., USA) was infused at iodosulpride as a ligand is shown. Two representative slices, which exhibited the highest levels of expression, were taken from four rats of each strain for each timepoint a concentration of 0.1 μM through the microdialysis probe and ACh levels were then analyzed using a high-performance liquid chromatographic assay. Figure 9 shows the striatal release of ACh when 0.1 μM quinpirole was infused in control-vector-injected or AdCMV.DopD 2 R-injected old rats. The old rats exhibited significantly less ACh decrease than the young controls (P=0.014). The AdCMV.DopD 2 R injection significantly restored the release of ACh of old rats (P=0.006). We documented a significant difference among the three groups (P<0.001) and also showed statistically significant differences between AdCMV.DopD 2 R and AdCMV.LacZ-injected old rats (P= 0.006), and between AdCMV.LacZ-injected young and old rats (P=0.014).
The response of cholinergic neurons in aged striatum was compatible with the results of our previous study when 0.1 μM of quinpirole was infused . The D 2 R gene-transferred rats showed significantly stronger responses of striatal cholinergic neurons to the D 2 R agonist infusion compared with control-vector-treated rats.
The successful restoration of age-associated functional decline of DA-ACh interactions in the striatum stimulated several suggestions. First, the age-associated decrease of D 2 R appears at least partly involved raclopride at day 3 after vector injection. The AP coordinate was -0.5 mm from the bregma. e Young rat; f old rat Fig. 8 Time-course of binding potential from day 2 or 3 to day 10 after vector injection in three age groups. Each rat of the three groups underwent three PET scans: n=8 for 5-months old, n=5 for 13-months old, and n=9 for 24-months old. Data at day 7 and day 10 were expressed as percentages of the AdCMV.DopD 2 R-injected side to AdCMV.LacZ-injected side ratio of binding potential at day 2 or day 3; i.e., the largest AdCMV.DopD 2 R-injected side to AdCMV.LacZ-injected side ratio observed at day 2 or day 3 in each group was normalized as 100. Data are expressed as mean ± SD. Repeated ANOVA showed significant difference among three groups (P=0.0112), and Scheffe's post-hoc analysis showed the significant difference between the 5-and 24-month-old groups at days 7 and day 10 (P=0.0007, and <0.0001, respectively) CMV.LacZ-injected striata of the three age groups (5, 13, 24 months) of rats 2 or 3 days after the vector injection (5C, 13C, and 24C stand for the Ad.CMV.LacZ-injected striata in 5-, 13-, and 24-month-old rats, respectively, and 5D, 13D, and 24D stand for the Ad.CMV.DopD 2 R-injected striata in 5-, 13-, and 24-month-old rats, respectively). All data were expressed mean ± SD (n=12-25). The paired t-test between Ad.CMV. DopD 2 R-injected side and Ad.CMV.LacZ-injected side in each age group showed significant increase of binding potential in Ad.CMV. DopD 2 R -injected side (P<0.01 in each age group). **P<0.01 The results are expressed as a percentage of the basal levels (calculated as the mean of the three samples before drug perfusion). Each point represents the mean ± SD. Quinpirole at the concentration of 0.1 μM was perfused through the microdialysis probe from 60 to 240 min after the experiment was begun. Repeated-measures ANOVA revealed a significant difference among three groups (P<0.001), and Scheffe's post-hoc analysis showed a statistically significant difference between AdCMV. DopD 2 R and AdCMV.LacZ-injected old rats (P=0.006), and between AdCMV.LacZ-injected young and old rats (P=0.014) in the mechanism affected by the age-associated deterioration of ACh control of dopaminergic input. Second, age-associated functional decline in the brain could be improved by several modalities including gene transfer. Third, the prevention of age-associated functional decline would be the best strategy; however, it also appeared that inverventions were possible after age-associated functional decline manifested. The challenge now is find interventions that can act in a longterm and safe fashion to maintain striatal function.
Summary
With age both functional and anatomical alterations occur in the nigrostriatum system. Of these alterations, decline of D 2 R numbers in the striatum is one of the most established features of mammalian brain aging. Functional interactions of DA and ACh in the striatum are also changed; specifically, inhibition of ACh release by D 2 R stimulation is reduced in aged striatum, possibly due to age-associated decrease of D 2 R in the cholinergic interneurons. By taking advantage of gene transfer technology, we demonstrated that D 2 R augmentation ameliorated the control of the ACh release by DA. Our studies suggested that age-associated decrease of D 2 R contributes to functional alteration of the interaction of DA and ACh in the striatum and these age-associated changes indeed are modifiable. Future studies are warranted to see if the functional restoration of the nigrostriatum DA system could lead to motor functional improvement in aged animals and by extension in aged humans.
